<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538209</url>
  </required_header>
  <id_info>
    <org_study_id>portal circulation assessment</org_study_id>
    <nct_id>NCT04538209</nct_id>
  </id_info>
  <brief_title>Effect of Variceal Eradication on Portal Circulation</brief_title>
  <official_title>Assessment of Portal Circulation Before and After Variceal Eradication in Patients With Liver Cirrhosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study the effect of variceal eradication on portal circulation, liver stiffness and&#xD;
      Child-Pugh and MELD scores in patients with liver cirrhosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Portosystemic collateral circulation is a consequence of portal hypertension, which occurs in&#xD;
      chronic liver disease and is responsible for numerous complications.&#xD;
&#xD;
      Gastric and oesophageal varices are two of common portosystemic collaterals, patients usually&#xD;
      presented with hematemesis, melena, or both, ultimately 20% is the mortality during the first&#xD;
      attack.&#xD;
&#xD;
      Although both band ligation and sclerotherapy are effective modalities of treatment in&#xD;
      controlling acute variceal bleeding, in preventing future variceal bleeding as well as in&#xD;
      eradicating varices with very few complications , their effects on portal circulation have&#xD;
      raised concerns among hepatologist.&#xD;
&#xD;
      Information about collateral pathways is especially relevant when interventional procedures&#xD;
      or surgery is indicated because inadvertent distribution of these vessels can cause&#xD;
      significant bleeding.&#xD;
&#xD;
      Few studies pointed on development of new portosystemic collaterals post variceal eradication&#xD;
      depending on abdominal computed tomography (CT ) compared to pre-variceal eradication as&#xD;
      showed paraoesophageal varices, retro-gastric varices not visualized with endoscopy ,or large&#xD;
      deep gastric collaterals that may increase risk for rebleeding.&#xD;
&#xD;
      Also, liver stiffness measurement and indirect markers of portal hypertension have been&#xD;
      correlated with the severity of portal hypertension and have been used to predict the&#xD;
      presence of varices, and there is rising question what about effect of variceal eradication&#xD;
      on liver stiffness.&#xD;
&#xD;
      The Child-Pugh and MELD scores were significantly higher for patients with gastric variceal&#xD;
      bleeding , and the question here is variceal eradication can improve Child-Pugh and MELD&#xD;
      scores or there is no effect.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study the effect of variceal eradication on portal circulation, liver stiffness and Child-Pugh and MELD scores in patients with liver cirrhosis.</measure>
    <time_frame>4 years</time_frame>
    <description>Study the effect of variceal eradication on portal circulation and development of new portosystemic collaterals had not be found before variceal eradication in patients with liver cirrhosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study the effect of variceal eradication on liver stiffness and Child-Pugh and MELD scores in patient with liver cirrhosis</measure>
    <time_frame>4 years</time_frame>
    <description>study how can variceal eradication affect liver elasticity, liver function so can calculate Child-Pugh and MELD scores which can life expectancy of patients with liver cirrhosis</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Portosystemic Collateral Veins</condition>
  <arm_group>
    <arm_group_label>canditates for variceal eradication</arm_group_label>
    <description>patients with documented liver cirrhosis (Based on clinical, laboratory and ultrasonographic findings) undergoing either primary or secondary prophylaxis variceal eradication at endoscopy unit of El-Rajhi hospital, Assuit University</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Abdominal computed tomography with angiography.</intervention_name>
    <description>technique of combing a Computed Tomography scan with the injection of dye to create pictures of the portal circulation and portosystemic collaterals veins.</description>
    <arm_group_label>canditates for variceal eradication</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with documented liver cirrhosis (Based on clinical, laboratory and&#xD;
        ultrasonographic findings) undergoing either primary or secondary prophylaxis variceal&#xD;
        eradication at endoscopy unit of El-Rajhi hospital, Assuit University.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Age between 18 and 70 years old.&#xD;
&#xD;
               -  Patient with documented liver cirrhosis undergoing either primary or secondary&#xD;
                  prophylactic variceal eradication.&#xD;
&#xD;
               -  Liver cirrhosis with Child-Pugh score A and B.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Age less than 18 years.&#xD;
&#xD;
               -  Have contraindications to computed abdominal CT-angiography (e.g. allergy to all&#xD;
                  suitable contrast agents, renal failure).&#xD;
&#xD;
               -  Patients with history of recent significant bleeding varices.&#xD;
&#xD;
               -  Previous history of variceal ligation, sclerotherapy, and TIPS operation.&#xD;
&#xD;
               -  Patients with isolated gastric varices.&#xD;
&#xD;
               -  Patients with HCC or other malignancies.&#xD;
&#xD;
               -  End-stage liver disease (Child score more than 9).&#xD;
&#xD;
               -  Patients with malignant portal vein thrombosis.&#xD;
&#xD;
               -  Patients with non-cirrhotic portal hypertension.&#xD;
&#xD;
               -  Patients refuse to participate in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esraa Swifee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esraa Swifee, M.A gastroenterology</last_name>
    <phone>+201000700150</phone>
    <email>esraayousef27@yahoo.com</email>
  </overall_contact>
  <reference>
    <citation>Abdel-Aty M, Fouad M, Sallam MM, Elgohary EA, Ismael A, Nawara A, Hawary B, Tag-Adeen M, Khaled S. Incidence of HCV induced-Esophageal varices in Egypt: Valuable knowledge using data mining analysis. Medicine (Baltimore). 2017 Jan;96(4):e5647. doi: 10.1097/MD.0000000000005647.</citation>
    <PMID>28121921</PMID>
  </reference>
  <reference>
    <citation>Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1. Erratum in: Hepatology. 2017 Jul;66(1):304.</citation>
    <PMID>27786365</PMID>
  </reference>
  <reference>
    <citation>Augustin S, Millán L, González A, Martell M, Gelabert A, Segarra A, Serres X, Esteban R, Genescà J. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study. J Hepatol. 2014 Mar;60(3):561-9. doi: 10.1016/j.jhep.2013.10.027. Epub 2013 Nov 6.</citation>
    <PMID>24211744</PMID>
  </reference>
  <reference>
    <citation>Lahbabi M, Mellouki I, Aqodad N, Elabkari M, Elyousfi M, Ibrahimi SA, Benajah DA. Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up. Pan Afr Med J. 2013 May 3;15:3. doi: 10.11604/pamj.2013.15.3.2098. Print 2013.</citation>
    <PMID>23847700</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 30, 2020</study_first_submitted>
  <study_first_submitted_qc>September 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>September 2, 2020</last_update_submitted>
  <last_update_submitted_qc>September 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Esraa Yousef Mohammed</investigator_full_name>
    <investigator_title>Assistant Lecturer of Tropical Medicine and Gastroenterology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

